A study in patients with solid tumors found that CRBSI is significantly linked to mortality in patients with PICCs, whereas CRT and CRLC are not significant risk factors.

Autonomix Medical receives European patent for proprietary catheter-based technology: The Woodlands, Texas Saturday, April 19, 2025, 14:00 Hrs [IST] Autonomix Medical, Inc., a med ...

New patent underscores breadth of application and expansion opportunities for Company’s catheter-based technology Continued progress with growing ...

The new Isuzu truck model range – specifically, the Isuzu Modular Architecture and Component Standard, otherwise known as I-MACS – has enabled a range of intelligent, innovative technological ...

US-based mobile healthcare services company Peak Mobile Holdings has acquired New England Vascular Access, expanding its ...

Winning The Challenge is hard enough when you’re at full strength. It’s a whole different beast when your body starts ...

Savolitinib plus osimertinib may be a chemotherapy-free treatment option for patients with EGFR-mutant, advanced NSCLC with MET overexpression/amplification whose disease has progressed on osimertinib ...

Nazrin Abdul Read more One of the defining discussions at the international forum on Facing the New World Order, hosted by ...

At a recent tech conference, a group of schoolchildren presented a fully functional AI-integrated school entry system.

In London, the outer borough of Havering was the quickest place for a home up for sale to go under offer, taking just 44 days on average.

Good morning, and welcome to Johnson & Johnson's First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode until the question-and-answer session of the conference. This ...